﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article article-type="case-report" dtd-version="1.1" specific-use="sps-1.9" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">rbof</journal-id>
			<journal-title-group>
				<journal-title>Revista Brasileira de Oftalmologia</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Rev. bras.oftalmol.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0034-7280</issn>
			<issn pub-type="epub">1982-8551</issn>
			<publisher>
				<publisher-name>Sociedade Brasileira de Oftalmologia</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="other">01827</article-id>
			<article-id pub-id-type="doi">10.37039/1982.8551.20260106</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Case Report</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Probable pediatric IgG4-related orbital disease presenting as a lacrimal gland mass</article-title>
				<trans-title-group xml:lang="pt">
					<trans-title>Doença orbitária pediátrica relacionada à IgG4 apresentando-se como massa em glândula lacrimal</trans-title>
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0009-0005-3289-543X</contrib-id>
					<name>
						<surname>Gomes</surname>
						<given-names>Bruno Campos</given-names>
					</name>
					<role>contributed to the investigation</role>
					<role>formal analysis of the findings</role>
					<role>preparation of the figures</role>
					<role>drafting of the manuscript</role>
					<role>critical review and editing of its content</role>
					<role>approved the final version of the manuscript and are accountable for all aspects of the work, including ensuring its accuracy and integrity</role>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="corresp" rid="c1"/>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0009-0004-0418-4254</contrib-id>
					<name>
						<surname>Souza</surname>
						<given-names>Jayana Rodrigues Lucas</given-names>
					</name>
					<role>contributed to the investigation</role>
					<role>formal analysis of the findings</role>
					<role>preparation of the figures</role>
					<role>drafting of the manuscript</role>
					<role>critical review and editing of its content</role>
					<role>approved the final version of the manuscript and are accountable for all aspects of the work, including ensuring its accuracy and integrity</role>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0009-0005-0556-6016</contrib-id>
					<name>
						<surname>Baptista</surname>
						<given-names>Gustavo Marum Barbosa</given-names>
					</name>
					<role>contributed to the investigation</role>
					<role>formal analysis of the findings</role>
					<role>preparation of the figures</role>
					<role>drafting of the manuscript</role>
					<role>critical review and editing of its content</role>
					<role>approved the final version of the manuscript and are accountable for all aspects of the work, including ensuring its accuracy and integrity</role>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-0235-8834</contrib-id>
					<name>
						<surname>Balbi</surname>
						<given-names>Gustavo Guimarães Moreira</given-names>
					</name>
					<role>contributed to the conceptualization of the study</role>
					<role>formal analysis of the findings</role>
					<role>drafting of the manuscript</role>
					<role>critical review and editing of its content</role>
					<role>approved the final version of the manuscript and are accountable for all aspects of the work, including ensuring its accuracy and integrity</role>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-8751-6795</contrib-id>
					<name>
						<surname>Matos</surname>
						<given-names>Aline Mota Freitas</given-names>
					</name>
					<role>contributed to the conceptualization of the study</role>
					<role>formal analysis of the findings</role>
					<role>drafting of the manuscript</role>
					<role>critical review and editing of its content</role>
					<role>approved the final version of the manuscript and are accountable for all aspects of the work, including ensuring its accuracy and integrity</role>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<aff id="aff1">
					<label>1</label>
					<institution content-type="orgname">Universidade Federal de Juiz de Fora</institution>
					<addr-line>
						<named-content content-type="city">Juiz de Fora</named-content>
						<named-content content-type="state">MG</named-content>
					</addr-line>
					<country country="BR">Brazil</country>
					<institution content-type="original">Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.</institution>
				</aff>
			</contrib-group>
			<author-notes>
				<corresp id="c1">
					<label>Corresponding author:</label> Name: Bruno Campos Gomes E-mail: <email>bruno.gomes.bcg@gmail.com</email>
				</corresp>
				<fn fn-type="coi-statement">
					<label>Conflict of interest:</label>
					<p>no conflict of interest.</p>
				</fn>
				<fn fn-type="edited-by">
					<label>Associate Editor:</label>
					<p>Renato Wendell Ferreira Damasceno, Universidade Estadual de Ciências da Saúde de Alagoas, Maceió, AL, Brazil; <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-9380-0335">https://orcid.org/0000-0002-9380-0335</ext-link>
					</p>
				</fn>
			</author-notes>
			<pub-date date-type="pub" publication-format="electronic">
				<day>11</day>
				<month>11</month>
				<year>2026</year>
			</pub-date>
			<pub-date date-type="collection" publication-format="electronic">
				<year>2026</year>
			</pub-date>
			<volume>85</volume>
			<elocation-id>e0106</elocation-id>
			<history>
				<date date-type="received">
					<day>05</day>
					<month>02</month>
					<year>2026</year>
				</date>
				<date date-type="accepted">
					<day>06</day>
					<month>09</month>
					<year>2026</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright ©2026</copyright-statement>
				<copyright-year>2026</copyright-year>
				<copyright-holder>The Author(s)</copyright-holder>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
					<license-p>All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<abstract>
				<title>ABSTRACT</title>
				<p>Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated fibroinflammatory condition characterized by tumefactive lesions, lymphoplasmacytic infiltration, and fibrosis. Orbital involvement is uncommon in children and may mimic infectious dacryoadenitis, idiopathic orbital inflammation, and lymphoproliferative disorders. We report the case of a 13-year-old girl with four days of left periorbital swelling and pain, associated with lacrimal gland enlargement on imaging. Biopsy showed fibrosis, dense lymphoplasmacytic infiltration, and reactive lymphoid aggregates. Immunohistochemistry demonstrated mixed B- and T-cell populations, polyclonal kappa/lambda plasma cells, and up to 31 IgG4-positive plasma cells per high-power field, with an IgG4/IgG ratio of 30%. Serum IgG4 was 76 mg/dL. Although the patient did not fulfill classical adult-based serological and histopathological criteria for definite IgG4-RD, the clinical, radiological, histopathological, and therapeutic-response findings supported a presumptive diagnosis of probable pediatric IgG4-related orbital disease. This case highlights the importance of orbital biopsy, exclusion of differential diagnoses, and cautious interpretation of adult diagnostic criteria in pediatric patients.</p>
			</abstract>
			<trans-abstract xml:lang="pt">
				<title>RESUMO</title>
				<p>A doença relacionada à imunoglobulina G4 (IgG4-RD) é uma condição fibroinflamatória imunomediada, caracterizada por lesões tumefativas, infiltrado linfoplasmocitário e fibrose. O acometimento orbitário é incomum em crianças e pode simular dacrioadenite infecciosa, inflamação orbitária idiopática e doenças linfoproliferativas. Relata-se o caso de uma paciente de 13 anos com edema e dor periorbitária à esquerda há 4 dias, associada a aumento da glândula lacrimal em exames de imagem. A biópsia demonstrou fibrose, infiltrado linfoplasmocitário denso e agregados linfoides reativos. A imuno-histoquímica evidenciou populações mistas de linfócitos B e T, plasmócitos policlonais kappa/lambda e até 31 plasmócitos IgG4-positivos por campo de grande aumento, com relação IgG4/IgG de 30%. O IgG4 sérico foi de 76 mg/dL. Embora a paciente não preenchesse critérios séricos e histopatológicos clássicos para diagnóstico definitivo em adultos, o conjunto clínico, radiológico, histopatológico e evolutivo sustentou o diagnóstico presuntivo de doença orbitária pediátrica provavelmente relacionada à IgG4. O caso ressalta a importância da biópsia orbitária, da exclusão de diagnósticos diferenciais e da interpretação cautelosa dos critérios diagnósticos adultos em pacientes pediátricos.</p>
			</trans-abstract>
			<kwd-group xml:lang="en">
				<title>Keywords:</title>
				<kwd>Orbit</kwd>
				<kwd>Inflammation</kwd>
				<kwd>Lacrimal apparatus</kwd>
				<kwd>Child</kwd>
				<kwd>Immunoglobulin G4-related disease</kwd>
			</kwd-group>
			<kwd-group xml:lang="pt">
				<title>Descritores:</title>
				<kwd>Órbita</kwd>
				<kwd>Inflamação</kwd>
				<kwd>Aparelho lacrimal</kwd>
				<kwd>Criança</kwd>
				<kwd>Doença relacionada a imunoglobulina G4</kwd>
			</kwd-group>
			<funding-group>
				<funding-statement><bold>Financial support:</bold> no financial support for this work.</funding-statement>
			</funding-group>
			<counts>
				<fig-count count="3"/>
				<table-count count="0"/>
				<equation-count count="0"/>
				<ref-count count="14"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<sec sec-type="intro">
			<title>INTRODUCTION</title>
			<p>Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated fibroinflammatory disorder characterized by tumefactive lesions, dense lymphoplasmacytic infiltration, variable fibrosis, and tissue infiltration by IgG4-positive plasma cells.<sup>(<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>)</sup> It may affect a single organ or occur as a systemic condition, with potential involvement of the pancreas, biliary tract, salivary glands, lacrimal glands, lymph nodes, retroperitoneum, lungs, thyroid, kidneys, and other organs.<sup>(<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>)</sup></p>
			<p>When the orbit and ocular adnexa are involved, the condition is termed IgG4-related ophthalmic disease or IgG4-related orbital disease (IgG4-ROD).<sup>(<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>)</sup> The lacrimal gland is one of the most frequently affected ophthalmic structures, although extraocular muscles, trigeminal nerve branches, orbital fat, eyelids, optic nerve sheath, lacrimal sac, cavernous sinus, and intracranial structures may also be involved.<sup>(<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B6">6</xref>)</sup> In adults, diagnosis is based on the integration of clinical-radiological findings, serum IgG4 levels, and histopathological criteria.<sup>(<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>)</sup> However, pediatric IgG4-RD remains poorly characterized, and children may present with normal serum IgG4 levels or incomplete histopathological criteria.<sup>(<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>)</sup></p>
			<p>This report describes a pediatric lacrimal gland mass with clinical, radiological, and immunohistochemical findings suggestive of probable IgG4-ROD. The case is relevant because it illustrates the diagnostic uncertainty that may occur when adult-derived criteria are applied to children, particularly in the absence of elevated serum IgG4. This case report was approved by the Research Ethics Committee of the Hospital Universitário da Universidade Federal de Juiz de Fora (UFJF) (CAAE: 85902824.8.0000.5133; approval date: March 24, 2025). Written informed consent for publication of the clinical data and images was obtained from the patient's legal guardian.</p>
		</sec>
		<sec sec-type="cases">
			<title>CASE REPORT</title>
			<p>A previously healthy 13-year-old girl presented with left periorbital swelling and mild ocular pain for four days. Ophthalmological examination revealed a palpable mass in the left lacrimal gland region, mild local hyperemia, warmth over the lesion, and a tense upper eyelid. Extraocular motility was preserved, and there was no proptosis, diplopia, or visual complaint. Pain was limited to local palpation (<xref ref-type="fig" rid="f1">Figure 1A</xref>).</p>
			<fig id="f1">
				<label>Figure 1</label>
				<caption>
					<title>(A) Preoperative lesion in the left lacrimal gland region; (B) lacrimal gland biopsy; (C): postoperative recovery.</title>
				</caption>
				<graphic xlink:href="0034-7280-rbof-85-e0106-gf01.tif"/>
			</fig>
			<p>Orbital computed tomography demonstrated enlargement of the left lacrimal gland with homogeneous contrast enhancement. Laboratory tests showed leukocytosis and elevated erythrocyte sedimentation rate. Orbital magnetic resonance imaging showed diffuse involvement of the left lacrimal gland, predominantly in the superolateral orbit, with isointense thickening on T1- and T2-weighted sequences and homogeneous gadolinium enhancement. (<xref ref-type="fig" rid="f2">Figure 2</xref>). Serum IgG4 was 76 mg/dL, below the usual cutoff adopted in adult diagnostic criteria.</p>
			<fig id="f2">
				<label>Figure 2</label>
				<caption>
					<title>Orbital magnetic resonance imaging: axial STIR sequence showing lacrimal gland involvement (A); coronal T1-weighted sequence showing isointense thickening (B); axial post-contrast T1-weighted fat-suppressed sequence showing homogeneous enhancement (C).</title>
				</caption>
				<graphic xlink:href="0034-7280-rbof-85-e0106-gf02.tif"/>
			</fig>
			<p>Because of the persistent lacrimal gland mass and the nonspecific clinical-radiological presentation, surgical biopsy was performed (<xref ref-type="fig" rid="f1">Figure 1B</xref>). The postoperative course was uneventful, with satisfactory local recovery (<xref ref-type="fig" rid="f1">Figure 1C</xref>). Histopathological analysis showed fibrosis, dense lymphoplasmacytic infiltration, and reactive lymphoid aggregates. Immunohistochemistry demonstrated mixed B-cell (CD20) and T-cell (CD3) populations. Plasma cells showed a mixed kappa/lambda pattern, without evidence of light-chain restriction in the available sample. IgG4 expression was identified in a subset of plasma cells, with up to 31 IgG4-positive plasma cells per high-power field and an IgG4/IgG ratio of 30% (<xref ref-type="fig" rid="f3">Figure 3</xref>).</p>
			<fig id="f3">
				<label>Figure 3</label>
				<caption>
					<title>Histology of the left lacrimal gland showing fibrosis, dense lymphoplasmacytic infiltrate, and reactive lymphoid aggregates. Immunohistochemistry demonstrates mixed B-cell (CD20) and T-cell (CD3) populations, polyclonal kappa/lambda plasma cells, and IgG4 expression in a subset of plasma cells, with up to 31 IgG4-positive cells per high-power field and an IgG4/IgG ratio of 30%.</title>
				</caption>
				<graphic xlink:href="0034-7280-rbof-85-e0106-gf03.tif"/>
			</fig>
			<p>The findings favored an IgG4-rich fibroinflammatory orbital lesion compatible with probable IgG4-ROD, although the case did not meet criteria for definite IgG4-RD according to adult-based comprehensive criteria. The main differential diagnoses considered were infectious dacryoadenitis, idiopathic orbital inflammation, orbital pseudotumor, Sjögren-related dacryoadenitis, granulomatous inflammatory disease, and ocular adnexal lymphoproliferative disorders. The presence of fibrosis, dense lymphoplasmacytic infiltrate, IgG4-positive plasma cells, preserved mixed B- and T-cell populations, and polyclonal plasma cells made a lymphoproliferative disorder less likely in the available diagnostic context.</p>
			<p>The patient was treated with methotrexate 15 mg weekly and folic acid 5 mg three times per week, associated with gradual corticosteroid tapering over three months. Follow-up included rheumatological evaluation, liver and renal function tests, and imaging assessment of the head, neck, thorax, abdomen, and pelvis, with no evidence of extraorbital disease. The clinical course was favorable under immunosuppressive treatment.</p>
		</sec>
		<sec sec-type="discussion">
			<title>DISCUSSION</title>
			<p>IgG4-ROD is an important cause of chronic orbital inflammation and may present as focal or diffuse enlargement of orbital adnexal structures.<sup>(<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B6">6</xref>)</sup> In adults, the disease classically manifests with painless eyelid swelling, lacrimal gland enlargement, proptosis, diplopia, extraocular muscle involvement, or infraorbital nerve enlargement.<sup>(<xref ref-type="bibr" rid="B3">3</xref>–<xref ref-type="bibr" rid="B6">6</xref>)</sup> Visual impairment is uncommon but may occur in severe cases, especially when orbital apex, optic nerve sheath, or compressive lesions are present.<sup>(<xref ref-type="bibr" rid="B4">4</xref>)</sup></p>
			<p>The present case differs from the typical adult presentation in three main aspects: young age, unilateral acute/subacute presentation, and absence of elevated serum IgG4. Pediatric IgG4-RD is rare and probably underrecognized. In a systematic review of pediatric cases, the median age was 13 years, and orbital involvement was among the most frequent presentations.<sup>(<xref ref-type="bibr" rid="B7">7</xref>)</sup> More recent pediatric reviews emphasize that children may show incomplete serological or histopathological findings and that adult classification or diagnostic criteria may not fully capture the pediatric spectrum.<sup>(<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>)</sup> Therefore, normal serum IgG4 should not completely exclude the diagnosis in children, especially when tissue findings and clinical-radiological features are suggestive.</p>
			<p>The diagnostic challenge in this case is central. According to the 2020 revised comprehensive diagnostic criteria, definite IgG4-RD requires characteristic organ involvement, serum IgG4 above 135 mg/dL, and pathological findings.<sup>(<xref ref-type="bibr" rid="B1">1</xref>)</sup> Pathological diagnosis requires positivity for at least two of the following: dense lymphocyte/plasma cell infiltration with fibrosis; IgG4/IgG ratio above 40% and more than 10 IgG4-positive plasma cells per high-power field; or typical tissue fibrosis, particularly storiform fibrosis, or obliterative phlebitis.<sup>(<xref ref-type="bibr" rid="B1">1</xref>)</sup> The patient had a characteristic lacrimal gland mass and dense lymphoplasmacytic infiltration with fibrosis, as well as more than 10 IgG4-positive plasma cells per high-power field. However, serum IgG4 was 76 mg/dL, and the IgG4/IgG ratio was 30%, below the classical 40% cutoff. Therefore, the most appropriate interpretation is not a definitive diagnosis, but a probable or presumptive IgG4-related orbital inflammatory disease.</p>
			<p>This distinction is important for scientific accuracy and directly addresses the main limitation of the case. The IgG4/IgG ratio has a diagnostic value, but cutoff values vary according to organ, sample quality, inflammatory background, and fibrosis.<sup>(<xref ref-type="bibr" rid="B10">10</xref>)</sup> A ratio of 30% is not sufficient to fulfill standard criteria, but it increases the probability of IgG4-RD when associated with compatible clinical-radiological findings, IgG4-positive plasma cell density, fibrosis, exclusion of mimickers, and treatment response.<sup>(<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B10">10</xref>)</sup> In pediatric patients, this interpretation must be particularly cautious, because the frequency and diagnostic weight of classic histological findings are less well established than in adults.<sup>(<xref ref-type="bibr" rid="B7">7</xref>–<xref ref-type="bibr" rid="B9">9</xref>)</sup></p>
			<p>The main differential diagnoses include idiopathic orbital inflammation, infectious dacryoadenitis, Sjögren-related dacryoadenitis, granulomatous diseases, and ocular adnexal lymphoma.<sup>(<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B11">11</xref>)</sup> Idiopathic orbital inflammation can present acutely with pain and swelling, often overlapping clinically with the initial findings in this case. Infectious dacryoadenitis may also present with local warmth, hyperemia, leukocytosis, and pain, but persistence of a mass-like lesion and the histopathological pattern favored a noninfectious fibroinflammatory process. Ocular adnexal lymphoma is a particularly important differential diagnosis because IgG4-positive plasma cells may be seen in lymphomas, and IgG4-producing MALT lymphoma can mimic IgG4-RD.<sup>(<xref ref-type="bibr" rid="B11">11</xref>)</sup> In this patient, the mixed B- and T-cell populations and polyclonal kappa/lambda plasma cells argued against a clonal lymphoproliferative process in the available sample.</p>
			<p>Treatment of IgG4-RD generally begins with systemic glucocorticoids when there is active symptomatic disease, risk of organ damage, or relevant functional impairment.<sup>(<xref ref-type="bibr" rid="B12">12</xref>)</sup> However, relapse after steroid tapering is common, and steroid-sparing immunosuppressive agents, including methotrexate, azathioprine, mycophenolate mofetil, and rituximab, may be considered in recurrent, persistent, or steroid-dependent disease.<sup>(<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B12">12</xref>)</sup> Pediatric evidence remains limited, but available reviews suggest that glucocorticoids are frequently used as first-line therapy and that steroid-sparing agents may be required in a relevant proportion of children.<sup>(<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B9">9</xref>)</sup> The favorable clinical course after methotrexate and corticosteroid tapering in this patient supports the inflammatory and immune-mediated nature of the lesion, although therapeutic response alone should not be used as definitive diagnostic proof.</p>
			<p>This report has limitations. First, the patient did not meet adult-based serological criteria for definite IgG4-RD. Second, the IgG4/IgG ratio was borderline and below the classical diagnostic threshold. Third, histological review by an additional reference pathologist was not available. For these reasons, the terminology &quot;probable&quot; or &quot;presumptive&quot; IgG4-ROD is more appropriate than &quot;confirmed&quot; IgG4-RD. Nevertheless, the case remains clinically relevant because it demonstrates the diagnostic complexity of pediatric IgG4-rich orbital inflammation and reinforces the need for biopsy, careful exclusion of mimickers, systemic evaluation, and long-term follow-up. These diagnostic challenges are consistent with broader discussions regarding the limitations of current IgG4-RD classification frameworks and with clinicopathological observations of IgG4-rich lesions in pediatric head and neck disease.<sup>(<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>)</sup></p>
			<p>In conclusion, pediatric IgG4-ROD may present as a unilateral lacrimal gland mass with normal serum IgG4 and incomplete adult diagnostic criteria. In such cases, diagnosis should be based on cautious integration of clinical, imaging, histopathological, immunohistochemical, and follow-up findings. Recognition of this entity is important to guide appropriate immunosuppressive therapy and avoid misclassification as infection, idiopathic orbital inflammation, or lymphoproliferative disease.</p>
		</sec>
	</body>
	<back>
		<fn-group>
			<fn fn-type="financial-disclosure" id="fn1">
				<label>Financial support:</label>
				<p>no financial support for this work.</p>
			</fn>
			<fn fn-type="other" id="fn2">
				<label>Institution:</label>
				<p>Universidade Federal de Juiz de Fora, Juiz de Fora, MG, Brazil.</p>
			</fn>
		</fn-group>
		<sec sec-type="data-availability" specific-use="data-available-upon-request">
			<title>Data availability statement:</title>
			<p>the data that support the findings of this study are not openly available but are available from the corresponding author upon reasonable request.</p>
		</sec>
		<ref-list>
			<title>REFERENCES</title>
			<ref id="B1">
				<label>1</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Umehara</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Okazaki</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Kawa</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Takahashi</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Goto</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Matsui</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Ishizaka</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Akamizu</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Sato</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Kawano</surname>
							<given-names>M</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD</article-title>
					<source>Mod Rheumatol</source>
					<year>2021</year>
					<volume>31</volume>
					<issue>3</issue>
					<fpage>529</fpage>
					<lpage>533</lpage>
				</element-citation>
				<mixed-citation>1 Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, Ishizaka N, Akamizu T, Sato Y, Kawano M, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31(3):529-33.</mixed-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Stone</surname>
							<given-names>JH</given-names>
						</name>
						<name>
							<surname>Zen</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Deshpande</surname>
							<given-names>V</given-names>
						</name>
					</person-group>
					<article-title>IgG4-related disease</article-title>
					<source>N Engl J Med</source>
					<year>2012</year>
					<volume>366</volume>
					<issue>6</issue>
					<fpage>539</fpage>
					<lpage>551</lpage>
				</element-citation>
				<mixed-citation>2 Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539-51.</mixed-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Goto</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Takahira</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Azumi</surname>
							<given-names>A</given-names>
						</name>
						<collab>Japanese Study Group for IgG4-Related Ophthalmic Disease</collab>
					</person-group>
					<article-title>Diagnostic criteria for IgG4-related ophthalmic disease</article-title>
					<source>Jpn J Ophthalmol</source>
					<year>2015</year>
					<volume>59</volume>
					<issue>1</issue>
					<fpage>1</fpage>
					<lpage>7</lpage>
				</element-citation>
				<mixed-citation>3 Goto H, Takahira M, Azumi A; Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59(1):1-7.</mixed-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Takahira</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Goto</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Azumi</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease</article-title>
					<source>Jpn J Ophthalmol</source>
					<year>2024</year>
					<volume>68</volume>
					<issue>4</issue>
					<fpage>293</fpage>
					<lpage>301</lpage>
				</element-citation>
				<mixed-citation>4 Takahira M, Goto H, Azumi A. The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2024;68(4):293-301.</mixed-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>McNab</surname>
							<given-names>AA</given-names>
						</name>
						<name>
							<surname>McKelvie</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>IgG4-related ophthalmic disease. Part I: Background and pathology</article-title>
					<source>Ophthalmic Plast Reconstr Surg</source>
					<year>2015</year>
					<volume>31</volume>
					<issue>2</issue>
					<fpage>83</fpage>
					<lpage>88</lpage>
				</element-citation>
				<mixed-citation>5 McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part I: Background and pathology. Ophthalmic Plast Reconstr Surg. 2015;31(2):83-8.</mixed-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Tiegs-Heiden</surname>
							<given-names>CA</given-names>
						</name>
						<name>
							<surname>Eckel</surname>
							<given-names>LJ</given-names>
						</name>
						<name>
							<surname>Hunt</surname>
							<given-names>CH</given-names>
						</name>
						<name>
							<surname>Diehn</surname>
							<given-names>FE</given-names>
						</name>
						<name>
							<surname>Schwartz</surname>
							<given-names>KM</given-names>
						</name>
						<name>
							<surname>Kallmes</surname>
							<given-names>DF</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Immunoglobulin G4-related disease of the orbit: imaging features in 27 patients</article-title>
					<source>AJNR Am J Neuroradiol</source>
					<year>2014</year>
					<volume>35</volume>
					<issue>7</issue>
					<fpage>1393</fpage>
					<lpage>1397</lpage>
				</element-citation>
				<mixed-citation>6 Tiegs-Heiden CA, Eckel LJ, Hunt CH, Diehn FE, Schwartz KM, Kallmes DF, et al. Immunoglobulin G4-related disease of the orbit: imaging features in 27 patients. AJNR Am J Neuroradiol. 2014;35(7):1393-7.</mixed-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Karim</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Loeffen</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Bramer</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Westenberg</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Verdijk</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>van Hagen</surname>
							<given-names>M</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>IgG4-related disease: a systematic review of this unrecognized disease in pediatrics</article-title>
					<source>Pediatr Rheumatol Online J</source>
					<year>2016</year>
					<volume>14</volume>
					<fpage>18</fpage>
					<lpage>18</lpage>
				</element-citation>
				<mixed-citation>7 Karim F, Loeffen J, Bramer W, Westenberg L, Verdijk R, van Hagen M, et al. IgG4-related disease: a systematic review of this unrecognized disease in pediatrics. Pediatr Rheumatol Online J. 2016;14:18.</mixed-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Taranto</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Bernardo</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Mauro</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Perrone</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Tamborino</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Giani</surname>
							<given-names>T</given-names>
						</name>
					</person-group>
					<article-title>IgG4-related disease in childhood: clinical presentation, management, and diagnostic challenges</article-title>
					<source>Children (Basel)</source>
					<year>2025</year>
					<volume>12</volume>
					<issue>7</issue>
					<fpage>888</fpage>
					<lpage>888</lpage>
				</element-citation>
				<mixed-citation>8 Taranto S, Bernardo L, Mauro A, Perrone A, Tamborino A, Giani T. IgG4-related disease in childhood: clinical presentation, management, and diagnostic challenges. Children (Basel). 2025;12(7):888.</mixed-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sapountzi</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Kotanidou</surname>
							<given-names>EP</given-names>
						</name>
						<name>
							<surname>Tsinopoulou</surname>
							<given-names>VR</given-names>
						</name>
						<name>
							<surname>Fotis</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Fidani</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Galli-Tsinopoulou</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>The management of IgG4-related disease in children: a systematic review</article-title>
					<source>Children (Basel)</source>
					<year>2025</year>
					<volume>12</volume>
					<issue>2</issue>
					<fpage>213</fpage>
					<lpage>213</lpage>
				</element-citation>
				<mixed-citation>9 Sapountzi E, Kotanidou EP, Tsinopoulou VR, Fotis L, Fidani L, Galli-Tsinopoulou A. The management of IgG4-related disease in children: a systematic review. Children (Basel). 2025;12(2):213.</mixed-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Masaki</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Kurose</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Yamamoto</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Takahashi</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Saeki</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Azumi</surname>
							<given-names>A</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Cutoff values of serum IgG4 and histopathological IgG4-positive plasma cells for diagnosis of patients with IgG4-related disease</article-title>
					<source>Int J Rheumatol</source>
					<year>2012</year>
					<volume>2012</volume>
					<fpage>580814</fpage>
					<lpage>580814</lpage>
				</element-citation>
				<mixed-citation>10 Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, et al. Cutoff values of serum IgG4 and histopathological IgG4-positive plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol. 2012;2012:580814.</mixed-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sato</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Ohshima</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Takata</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Huang</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Cui</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Ohno</surname>
							<given-names>K</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease</article-title>
					<source>J Clin Exp Hematop</source>
					<year>2012</year>
					<volume>52</volume>
					<issue>1</issue>
					<fpage>51</fpage>
					<lpage>55</lpage>
				</element-citation>
				<mixed-citation>11 Sato Y, Ohshima K, Takata K, Huang X, Cui W, Ohno K, et al. Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease. J Clin Exp Hematop. 2012;52(1):51-5.</mixed-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Khosroshahi</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Wallace</surname>
							<given-names>ZS</given-names>
						</name>
						<name>
							<surname>Crowe</surname>
							<given-names>JL</given-names>
						</name>
						<name>
							<surname>Akamizu</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Azumi</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Carruthers</surname>
							<given-names>MN</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Second International Symposium on IgG4-Related Disease. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease</article-title>
					<source>Arthritis Rheumatol</source>
					<year>2015</year>
					<volume>67</volume>
					<issue>7</issue>
					<fpage>1688</fpage>
					<lpage>1699</lpage>
				</element-citation>
				<mixed-citation>12 Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al.; Second International Symposium on IgG4-Related Disease. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015;67(7):1688-99.</mixed-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Katz</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Stone</surname>
							<given-names>JH</given-names>
						</name>
					</person-group>
					<article-title>Clinical perspectives on IgG4-related disease and its classification</article-title>
					<source>Annu Rev Med</source>
					<year>2022</year>
					<volume>73</volume>
					<fpage>545</fpage>
					<lpage>562</lpage>
				</element-citation>
				<mixed-citation>13 Katz G, Stone JH. Clinical perspectives on IgG4-related disease and its classification. Annu Rev Med. 2022;73:545-62.</mixed-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bu</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Koo</surname>
							<given-names>SC</given-names>
						</name>
					</person-group>
					<article-title>Clinicopathologic characterization of pediatric head and neck IgG4-rich lesions</article-title>
					<source>Arch Pathol Lab Med</source>
					<year>2022</year>
					<volume>146</volume>
					<issue>5</issue>
					<fpage>611</fpage>
					<lpage>618</lpage>
				</element-citation>
				<mixed-citation>14 Bu F, Koo SC. Clinicopathologic characterization of pediatric head and neck IgG4-rich lesions. Arch Pathol Lab Med. 2022;146(5):611-8.</mixed-citation>
			</ref>
		</ref-list>
	</back>
</article>